In a tweet on Friday, the watchdog said it has approved acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures as well as Optimus Drug's purchase of stakes in Optimus Pharma and Optimus Life Science.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9kudvKw
via IFTTT
0 comments:
Post a Comment